Immunocore Holdings plc IMCR

Updated: 17 Jun 2026

NASDAQ | Biotech | TCR bispecific immunotherapies

No signal published yet

We already track Immunocore Holdings and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Immunocore Holdings free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
TCR bispecific immunotherapies
We're already tracking Immunocore Holdings plc — here are the latest events we've registered

Recent News

  • On May 31, 2026, Immunocore presented updated Phase 1 data for brenetafusp in advanced melanoma. The company reported Q1 2026 net sales of $106.7 million for KIMMTRAK, a 14% increase year-over-year. In April 2026, five-year survival data for KIMMTRAK showed a doubling of survival probability in certain metastatic uveal melanoma patients.

What Firelda Watch includes for Immunocore Holdings plc

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Immunocore Holdings plc will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Moderna, Inc.
MRNA
HOLD
AstraZeneca PLC
AZN
HOLD
Calliditas Therapeutics
CALT
NEUTRAL
Ionis Pharmaceuticals, Inc.
IONS
HOLD
Exelixis, Inc.
EXEL
HOLD

Biotech

More companies in this sector

Want to follow Immunocore Holdings plc? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Immunocore Holdings free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Immunocore Holdings plc IMCR
Immunocore Holdings — follow and we'll monitor it
Follow Immunocore Holdings free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.